Sana Biotechnology
SANA
116 hedge funds and large institutions have $808M invested in Sana Biotechnology in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 37 reducing their positions, and 12 closing their positions.
171% more call options, than puts
Call options by funds: $333K | Put options by funds: $123K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
3.22% more ownership
Funds ownership: 63% → 66.22% (+3.2%)
5% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 37
1% less funds holding
Funds holding: 117 → 116 (-1)
18% less capital invested
Capital invested by funds: $986M → $808M (-$178M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$14.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.36M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.54M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$6.5M |
| 2 |
Morgan Stanley
New York
|
-$5.47M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$1.46M |
| 4 |
PGP
Prescott General Partners
Boca Raton,
Florida
|
-$1.23M |
| 5 |
Two Sigma Investments
New York
|
-$1.15M |
SANA Hedge Fund Activity: Q2 2022 in Review
116 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q2 2022, worth a combined $808M — down 18% from $986M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new SANA positions and 12 closed out — a net gain of 2 holders — while 39 added to existing stakes and 37 trimmed.
The largest buyer was Public Sector Pension Investment Board (PSP Investments), adding an estimated $14.5M. The largest seller was Capital International Investors, cutting an estimated $6.5M.
- 116 institutional investors held Sana Biotechnology (SANA) as of Q2 2022, down from 117 in Q1 2022.
- Funds reported $808M of Sana Biotechnology stock for Q2 2022, down 18% quarter-over-quarter.
- 14 funds opened new Sana Biotechnology positions in Q2 2022 and 12 closed out, a net change of +2 holders.
- The largest Sana Biotechnology buyer in Q2 2022 was Public Sector Pension Investment Board (PSP Investments), an estimated $14.5M added.
- The largest Sana Biotechnology seller in Q2 2022 was Capital International Investors, an estimated $6.5M sold.
Based on aggregated 13F filings for Q2 2022.